Anti-TNF-alpha Trough Level Measurements in Inflammatory Bowel Disease

NCT02073526 · clinicaltrials.gov ↗

COMPLETED

Status

1230

Enrollment

OTHER

Sponsor class

Conditions

Inflammatory Bowel Disease
Crohn's Disease
Ulcerative Colitis

Interventions

DRUG: Infliximab, adalimumab, certolizumab pegol

Sponsor

Oslo University Hospital